Health-related quality of life in non-transplant eligible newly diagnosed multiple myeloma patients treated with melphalan/prednisolone plus either thalidomide or lenalidomide; results of the HOVON87/NMSG18 study. Quality of Life Research

Publikation: Bidrag til tidsskriftKonferenceabstrakt i tidsskriftForskningpeer review

OriginalsprogEngelsk
TidsskriftQuality of Life Research
Vol/bind26
Udgave nummerSuppl. 1
Sider (fra-til)56-57
ISSN0962-9343
StatusUdgivet - okt. 2017
Begivenhed24th Annual Conference of the International Society for Quality of Life Research, - Philadelphia, USA
Varighed: 18. okt. 201721. okt. 2017

Konference

Konference24th Annual Conference of the International Society for Quality of Life Research,
LandUSA
ByPhiladelphia
Periode18/10/201721/10/2017

Citer dette

@article{5a5654cb3700413792d3855f834167ba,
title = "Health-related quality of life in non-transplant eligible newly diagnosed multiple myeloma patients treated with melphalan/prednisolone plus either thalidomide or lenalidomide; results of the HOVON87/NMSG18 study. Quality of Life Research",
author = "{Kongsgaard Nielsen}, Lene",
year = "2017",
month = "10",
language = "English",
volume = "26",
pages = "56--57",
journal = "Quality of Life Research",
issn = "0962-9343",
publisher = "Springer",
number = "Suppl. 1",

}

TY - ABST

T1 - Health-related quality of life in non-transplant eligible newly diagnosed multiple myeloma patients treated with melphalan/prednisolone plus either thalidomide or lenalidomide; results of the HOVON87/NMSG18 study. Quality of Life Research

AU - Kongsgaard Nielsen, Lene

PY - 2017/10

Y1 - 2017/10

M3 - Conference abstract in journal

VL - 26

SP - 56

EP - 57

JO - Quality of Life Research

JF - Quality of Life Research

SN - 0962-9343

IS - Suppl. 1

ER -